ALICIA NOVAK: Open Payments
NPI 1902314180 · OLYPHANT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$983 in 29 payments from 12 companies in 2025. Trend: 2023 $2,310 · 2024 $2,164 · 2025 $983
Food & beverage: $983
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $291 |
| Lilly USA, LLC | 13 | $231 |
| Boston Scientific Corporation | 1 | $137 |
| Actelion Pharmaceuticals US, Inc. | 1 | $122 |
| ABBVIE INC. | 4 | $70 |
| Novo Nordisk Inc | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Antares Pharma, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| Abbott Laboratories | 1 | $16 |
Products named: SYMPLICITY G3, General - Pain Management, ZEPBOUND, UPTRAVI, CATALYFT PL EXPANDABLE INTERBODY SYSTEM, MOUNJARO, JARDIANCE, VRAYLAR.
Industry payments across PA — which companies pay providers there.
